Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
N Engl J Med. 2022 Dec 15;387(24):2211-2219. doi: 10.1056/NEJMoa2206663.
N Engl J Med. 2022.
PMID: 36516090
Clinical Trial.